ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: FR-PO371

Hypoxia Attenuates Tubulointerstitial Injury, Inflammation, and Oxidative Stress in the Adenine Overload Model

Session Information

  • CKD: Mechanisms - II
    November 08, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: CKD (Non-Dialysis)

  • 2103 CKD (Non-Dialysis): Mechanisms

Authors

  • Zambom, Fernanda FF, Univ of Sao Paulo, Sao Paulo, Brazil
  • Tessaro, Helena Mendonca, Univ of Sao Paulo, Sao Paulo, Brazil
  • Albino, Amanda H., Univ of Sao Paulo, Sao Paulo, Brazil
  • Foresto-Neto, Orestes, Univ of Sao Paulo, Sao Paulo, Brazil
  • Pião, Janice, Univ of Sao Paulo, Sao Paulo, Brazil
  • Malheiros, Denise M., Univ of Sao Paulo, Sao Paulo, Brazil
  • Camara, Niels Olsen Saraiva, Univ of Sao Paulo, Sao Paulo, Brazil
  • Fujihara, Clarice K., Univ of Sao Paulo, Sao Paulo, Brazil
  • Zatz, Roberto, Univ of Sao Paulo, Sao Paulo, Brazil
Background

Adenine excess (ADE) leads to renal deposition of crystals (Crys) and tubulointerstitial nephritis via NFκB. Tissue hypoxia (HYP) has been considered a pathogenic factor in Chronic Kidney Disease (CKD). We showed recently that chronic HYP was renoprotective in rats with 5/6 renal ablation (Nx). Here we investigated a possible beneficial effect of HYP in ADE.

Methods

Male Munich-Wistar rats received standard (C) or 0.5% ADE chow. Six C and 8 ADE rats breathed 21% O2 (NOR), while 8 C and 8 ADE rats were kept under 12% O2 (HYP). After 2 wk, we assessed hemoglobin (Hb, g/dL), tail-cuff pressure (TCP, mmHg), urine albumin/creatinine (Ualb/Ucr), left kidney/body weight (x100), crystal density (Crys/mm2), urine KIM1 (ng/mL), cortical macrophages (MΦ) and angiotensin II+ (AII+) cells/mm2 and collagen-1 (%Coll-1), as well as the renal content of nuclear p65, IL6, CASP1, HO1, SOD1 (WB) and IL1β (pg/mg). Renal HYP was confirmed by pimonidazole staining. .

Results

HYP reduced renal hypertrophy, tubular injury, interstitial inflammation/fibrosis and the content of p65 and IL6, but not CASP1 or IL1β, suggesting specific NFκB inhibition, while lowering HO1 and increasing SOD1.

Conclusion

As in Nx, breathing 12% O2 limited renal injury in the ADE model and attenuated NFκB and oxidative stress, suggesting the existence of a common pathogenic mechanism and the need to review the role of tissue hypoxia in CKD. FAPESP/CNPq.

 CNORADENORCHYPADEHYP
Hb13±114±116±1*16±1#
TCP148±3162±3*146±2161±3*
UALB/UCR0.1±0.10.4±0.1*0.2±0.1*0.2±0.1#
LKW/BW0.5±0.10.9±0.1*0.4±0.10.7±0.1*#
Crys-44±4-40±4
KIM-10.2±0.110.2±1.6*0.2±0.14.6±1.8#
27±5366±20*24±2201±14*#
AII3±17±1*2±13±1#
%Coll-12.5±0.18.8±0.3*2.5±0.25.2±0.3*#
p651.0±0.12.5±0.4*1.3±0.11.2±0.2#
IL61.0±0.13.1±0.3*1.1±0.22.4±0.2*#
CASP11.0±0.12.8±0.3*1.7±0.42.3±0.3
IL1β2.1±0.318.4±1.71.8±0.217.5±2.3
HO11.0±0.12.6±0.3*0.8±0.11.9±0.2*#
SOD11.0±0.10.2±0.1*0.9±0.20.4±0.1*#

Mean±SE;*p<0.05 vs C, #p<0.05 vs ADENOR

Funding

  • Government Support - Non-U.S.